Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma.
about
Management of Oropharyngeal Cancer in the HPV Era.Management of locally advanced HPV-related oropharyngeal squamous cell carcinoma: where are we?Treatment-related outcome of oropharyngeal cancer patients differentiated by HPV dictated risk profile: a tertiary cancer centre series analysis.Increase in primary surgical treatment of T1 and T2 oropharyngeal squamous cell carcinoma and rates of adverse pathologic features: National Cancer Data Base.Is There a Role for Robotic Surgery in the Treatment of Head and Neck Cancer?Current Role of Surgery in the Management of Oropharyngeal CancerTransoral Robotic Surgery and the Unknown Primary: A Cost-Effectiveness Analysis.Management of the lymph node-positive neck in the patient with human papillomavirus-associated oropharyngeal cancer.Prognostic factors and survival unique to surgically treated p16+ oropharyngeal cancer.Oral cavity and oropharyngeal squamous cell carcinoma in young adults: a review of the literature.Management of human papillomavirus-related unknown primaries of the head and neck with a transoral surgical approach.Update on De-intensification and Intensification Studies in HPV.PIK3CA, HRAS and PTEN in human papillomavirus positive oropharyngeal squamous cell carcinoma.PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer.Transoral laser microsurgery for oropharyngeal squamous cell carcinoma: A paradigm shift in therapeutic approach.Minimally invasive surgery versus radiotherapy/chemoradiotherapy for small-volume primary oropharyngeal carcinoma.New insights into human papillomavirus-associated head and neck squamous cell carcinoma.Inter- and intra-observer variability in the classification of extracapsular extension in p16 positive oropharyngeal squamous cell carcinoma nodal metastasesOutcome and prognostic factors in T4a oropharyngeal carcinoma, including the role of HPV infection.Prognostic biological features in neck dissection specimens.New treatment strategies for HPV-positive head and neck cancer.Should patients with HPV-positive or negative tumors be treated differently?The role of postoperative chemoradiation for oropharynx carcinoma: a critical appraisal of the published literature and National Comprehensive Cancer Network guidelines.Imaging characteristics of metastatic nodes and outcomes by HPV status in head and neck cancers.Tumour-node-metastasis staging of human papillomavirus negative upper aerodigestive tract cancers: a critical appraisal.Influence of extracapsular nodal spread extent on prognosis of oral squamous cell carcinoma.Risk factors for locoregional relapse after transoral robotic surgery for human papillomavirus-related oropharyngeal squamous cell carcinoma.Variation in use of postoperative chemoradiation following surgery for T1 and T2 oropharyngeal squamous cell carcinoma; National Cancer Database.The Role of Adjuvant Chemotherapy in Surgically Managed, p16-Positive Oropharyngeal Squamous Cell Carcinoma.Pathologic Markers in Surgically Treated HPV-Associated Oropharyngeal Cancer: Retrospective Study, Systematic Review, and Meta-analysis.The prognostic value of extranodal extension in human papillomavirus-associated oropharyngeal squamous cell carcinoma.Oncologic outcomes of selective neck dissection in HPV-related oropharyngeal squamous cell carcinoma.Tumor Staging and HPV-Related Oropharyngeal Cancer.Treatment de-intensification strategies for head and neck cancer.Outcomes of surgically treated human papillomavirus-related oropharyngeal squamous cell carcinoma with N3 disease.Pathology-based staging for HPV-positive squamous carcinoma of the oropharynx.Overview of the 8th Edition TNM Classification for Head and Neck Cancer.[The 8th edition of the AJCC Cancer Staging Manual : Updates in otorhinolaryngology, head and neck surgery].Definitive Surgical Therapy after Open Neck Biopsy for HPV-Related Oropharyngeal Cancer.The impact of transoral robotic surgery on the overall treatment of oropharyngeal cancer patients.
P2860
Q30248326-329FFFBE-CE81-4906-8D12-9A9E11C70722Q30252081-BD876BC0-A87D-4BF2-8176-D80A4E0064F6Q30650708-76AC3C38-5C09-4AD1-95F7-155619C5448FQ31057384-0D5D21CA-CC27-44F2-839B-972E26F7E001Q33652561-9119ACB7-F9E6-47E0-974C-DF1EBA2AA2E7Q33652572-9C0A92ED-6136-4A67-97DB-DE94784944F1Q34207292-F5D7D419-AE83-4A06-BBAE-D87AADDE6297Q34232203-90238316-5B40-4059-93FA-CB854B1C7A51Q34394972-429CD15A-342B-40E5-8E95-CBBD3A6A0DFBQ34407889-7F03BC50-69F8-48C9-BCFC-A8977CFBAF16Q34424944-6CE34CE9-3B94-418E-AB1C-CC13A301117DQ34541908-1C8874C2-EA2D-449A-B014-9C32318BAF5FQ35068192-F970AD0B-7B92-4B20-9E00-91438D95B6FAQ35756867-7119771F-83AA-4CF2-A00F-3FFA576BC39AQ35978949-53EE3253-D769-4E8C-A0E5-8FB9017F137BQ36220456-BE851074-215A-43D6-A8F5-6E8E6C8D9121Q36880375-D74F7E2E-1D58-44C4-9982-E039F3093A39Q36923501-E9490820-858F-4F65-B2E6-30397E4CF29DQ37706474-13C0E669-3047-4383-AC5F-C1C17B2DE044Q38043916-91A3B45B-EB3E-4DED-8E76-D4E66130CF38Q38128210-82E5152D-A552-4439-9FA4-9B9207A1B950Q38202544-82796DB0-F1A4-4EC5-B4D2-E33F52E885C4Q38318325-AEFCFA14-4653-4CB2-8118-B814D0AC19D3Q38582025-6B7260A2-EFBD-4BA1-8CD5-566CAC67770BQ38601822-2E1C1B2F-BF82-496B-976E-3BE5561B2297Q38619411-5EEC67D2-CB96-4613-8459-6EABCFA0321CQ38669471-FA66298B-FA06-4B3E-BE2F-1F3FF4B83068Q38676179-55026760-43F7-4C5C-871D-D495F7B8BB37Q38787073-3CF5E3DA-0295-44CD-8E31-7D2149B8A9EAQ38842976-517D25AF-E0D7-40B4-BAF9-6717EDC15E84Q38890716-998F35CB-41F2-4DF7-8DA5-479E2DA97F6AQ38955757-8632D375-3BCA-4CBB-A292-47911DB53118Q38971551-4CF0EE7B-4654-4AF0-92DD-2CE8F7BD3FC3Q38984523-C153FD64-8002-475C-A51C-F31AB012F9FDQ39051213-22A2577D-5EA7-4C0A-90F3-3F6C5010B6D6Q39172238-7F0EDE9F-66FA-4A46-A5D5-A0FF33E38F1EQ39337270-5423D4E4-1A9F-4818-AC6A-2A4DE39396F2Q40130721-EA505474-0575-4343-A92B-BA4D22A3DD8DQ40919571-B5D1F176-6461-4A25-B89A-92DD92287FF1Q40966363-6B8DA240-9FFA-4B2C-BC59-52EE156A7F61
P2860
Extracapsular spread and adjuvant therapy in human papillomavirus-related, p16-positive oropharyngeal carcinoma.
description
2011 nî lūn-bûn
@nan
2011 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@ast
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@en
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@nl
type
label
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@ast
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@en
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@nl
prefLabel
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@ast
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@en
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
Extracapsular spread and adjuv ...... itive oropharyngeal carcinoma.
@en
P2093
Bruce H Haughey
Dorina Kallogjeri
James S Lewis
Jay F Piccirillo
Parul Sinha
P2860
P304
P356
10.1002/CNCR.26671
P407
P577
2011-11-15T00:00:00Z